v3.25.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities    
Net loss from continuing operations $ (521,638) $ (1,339,641)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 218,131 1,035,356
Amortization of debt discounts 15,926
Depreciation expense 2,023 1,412
Amortization of right-of-use asset 9,653 2,994
Loss on settlement (20,003)
Decrease (increase) in assets:    
Prepaids and other current assets 8,380 262,907
Increase (decrease) in liabilities:    
Accounts payable 74,323 57,550
Accrued expenses 23,679 7,651
Accrued expenses – related parties 29,174 (7,500)
Lease liability (9,899) (8,678)
Net cash used in operating activities (150,248) (7,952)
Cash flows from investing activities    
Purchase of fixed assets (1,731)
Net cash used in investing activities (1,731)
Cash flows from financing activities    
Proceeds from notes payable 97,500 20,000
Proceeds from sale of Series C Preferred shares 100
Proceeds from sale of Series D Preferred shares and warrants, net of fees 57,484
Payment of deferred offering costs (65,000)
Net cash provided by (used in) financing activities 154,984 (44,900)
Net increase (decrease) in cash 4,736 (54,583)
Cash – beginning 38,118 91,166
Cash – ending 42,854 36,583
Supplemental disclosures:    
Interest paid
Income taxes paid
Non-cash investing and financing activities:    
Amortization of deferred offering costs $ 2,297